Virus News and Research

Latest Virus News and Research

Study reveals mechanism underlying HBV-induced liver inflammation

Chronic hepatitis B virus (HBV) infection remains a major cause of global liver morbidity, leading to progressive necroinflammation that often culminates in cirrhosis and hepatocellular carcinoma.

17 Jul 2026

New battery-powered device detects Bundibugyo Ebola virus in thirty minutes

Professor Yasutoshi Kido of the Graduate School of Medicine, Osaka Metropolitan University (OMU), in collaboration with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) of the Democratic Republic of the Congo, is developing a portable rapid diagnostic system for Ebola virus disease (EVD) caused by Bundibugyo virus (BDBV).

17 Jul 2026

Bundibugyo Virus Disease outbreak

As of 14 July, 2,093 confirmed cases of Bundibugyo Virus Disease and 798 deaths had been reported in the DRC and Uganda. A total of 394 people have recovered.

17 Jul 2026

Global child immunization rates stall despite minor pandemic recovery

In 2025, 90% of infants globally – or nearly 116 million – received at least one dose of a diphtheria, tetanus and pertussis (DTP) vaccine, and 85% – or 110 million – completed the full three-dose series, according to the annual WHO-UNICEF Estimates of National Immunization Coverage (WUENIC) released today.

15 Jul 2026

Tick-borne viruses show concerning potential for future pandemics

A study led by a University of California, Riverside biomedical scientist shows how a family of tick-borne viruses known as orthonairoviruses can evade immune defenses, offering important insights into emerging infectious disease threats and the potential pandemic risk posed by these viruses.

14 Jul 2026

Tracking Lassa fever survivors provides crucial clues for future vaccines

The University of Maryland School of Medicine Center for Vaccine Development and Global Health (CVD), has announced the launch of a research study to understand how Lassa fever survivors fight and overcome Lassa virus infection.

14 Jul 2026

Researchers uncover how emerging tick borne nairoviruses evade human immunity

Warmer temperatures bring out ticks that spread diseases such as Lyme disease and Rocky Mountain spotted fever.

14 Jul 2026

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, presents new data further supporting the multi-component concept of its cytomegalovirus (CMV) vaccine program EVX-V1.

14 Jul 2026

Wild carnivores reveal wider West Nile and Usutu virus exposure in the Netherlands

Researchers detected Usutu virus RNA in nine of 818 wild carnivores sampled across the Netherlands, while no animals tested positive for West Nile virus RNA. Neutralizing antibodies to one or both viruses in red foxes and stone martens indicate broader spillover exposure and suggest these species may support arbovirus surveillance.

14 Jul 2026

New study tracks early genetic changes in hepatitis E virus

Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability.

13 Jul 2026

Animal-free lung model unlocks better treatments for RSV in babies

Future therapies for respiratory syncytial virus (RSV) must target both the virus and its immune response to ensure babies get the best possible outcomes, finds a new study by researchers at UCL and Great Ormond Street Hospital for Children (GOSH).

13 Jul 2026

New viral library helps scientists study thousands of proteins

To prevent viruses from sickening or killing us - whether it's an individual case of hepatitis B or a COVID pandemic - it's crucial to understand how the proteins they make initiate changes in our bodies that allow them to flourish.

11 Jul 2026

Cruise ship pollution increases risk of viral infections in ports

Air pollution from cruise ships could be damaging the health of people living in port cities by increasing inflammation and susceptibility to viruses such as the common cold and COVID-19.

11 Jul 2026

Exposure to port-derived particles facilitates the replication of COVID-19 and cold viruses

Air pollution from cruise ships could be damaging the health of people living in port cities by increasing inflammation and susceptibility to viruses such as the common cold and COVID-19.

10 Jul 2026

Discovery could pave the way for future vaccines against genital herpes

Researchers at the University of Gothenburg have identified a key protein that allows the virus that causes genital herpes to get into the nervous system.

9 Jul 2026

Review highlights traditional Chinese medicine for Chikungunya fever management

Chikungunya fever, caused by Chikungunya virus (CHIKV), has re‑emerged as a major global health threat. The 2025 outbreak in Guangdong, China – the largest local epidemic ever recorded – marks a critical epidemiological turning point.

9 Jul 2026

GLP-1 drugs may reduce lung scarring from Long COVID in diabetic patients

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well.

9 Jul 2026

New genetic screening method unlocks insights into human development

A new genetic screening method allows researchers to efficiently modulate individual genes across entire tissues and provides new insights into human development.

9 Jul 2026

Smoking shows no major impact on the eye microbiome in small study

A small study found no evidence that smoking causes large or consistent shifts in the ocular surface microbiome or tear proteome. The authors caution that subtle smoking-related effects cannot be ruled out, given the small cohort and the ocular surface's low-biomass, contamination-sensitive microbial niche.

8 Jul 2026

Weill Cornell Medicine receives federal grant to study new gene therapy for Alzheimer's disease

The National Institute on Aging of the National Institutes of Health has awarded a five-year grant initially worth $8.37 million for Weill Cornell Medicine researchers to study a new gene therapy for Alzheimer's disease in people who have a high genetic risk of developing the condition.

8 Jul 2026